  Drs. Dharam Kumbhani, Ki Park, and Ajay Kirtane review the late-breaking clinical trials from Wednesday, Oct. 25 at TCT 2023, including AGENT IDE (0:45), T-PASS (3:44), and SWEDEHEART (6:50).  For trial summaries, news coverage, daily video wrap-ups and more, visit ACC's Meeting Coverage Page (linked here) Follow the ACC on Social Media (linked here) and use the hashtag #TCT2023.    (https://twitter.com/hashtag/TCT2023).      Subscribe to Eagle’s Eye View   

Eagle’s Eye View: Wednesday, October 25 — ACCess Points Daily Wrap Up | TCT 2023

The weekly cardiovascular update from ACC.org Editor-in-Chief Kim Eagle, MD, MACC, covering the hottest cardiovascular topics, from new clinical guidelines to practice-changing research and innovative quality initiatives and tools.

Education

Training

Language Courses

Higher Education

K-12

Educational Technology

Medicine

Science & Medicine

Health & Fitness

 In this week’s View, Dr. Eagle looks at the recently released guidelines for lower extremity peripheral arterial disease (PAD). He then examines a national community-based cohort study on contemporary decongestion strategies in patients hospitalized for heart failure. Finally, Dr. Eagle shares some thoughts on the implications of discordance among ApoB, non–high-density lipoprotein cholesterol and triglycerides for cardiovascular prevention.    Subscribe to Eagle’s Eye View   

Guideline for the Management of Lower Extremity Peripheral Artery Disease (PAD), Decongestion Strategies for Heart Failure, Lipoproteins and Triglycerides in Cardiovascular Prevention

 In this week’s View, Dr. Eagle looks at the new AHA/ACC Hypertrophic Cardiomyopathy Guideline, then examines a randomized clinical trial that studied smoking cessation after initial treatment failure with varenicline or nicotine. Finally, Dr. Eagle shares some thoughts on a clinical consensus statement of the ESC Council on Stroke, the European Association of Cardiovascular Imaging, and the European Heart Rhythm Association of the ESC on embolic strokes of an undetermined source.    Subscribe to Eagle’s Eye View   

Eagle’s Eye View: The New AHA/ACC Hypertrophic Cardiomyopathy Guideline, Smoking Cessation, Embolic Stroke

 In this week’s View, Dr. Eagle looks at the durability of pulmonary vein isolation using pulsed-field ablation, then examines genetic penetrance of dilated cardiomyopathy in genotype-positive relatives. Finally, Dr. Eagle shares some thoughts on reinterventions after CoreValve/Evolut TAVR or SAVR for treatment of severe aortic stenosis.    Subscribe to Eagle’s Eye View   

Eagle’s Eye View: Pulsed Field Ablation and Pulmonary Vein Isolation, Penetrance of Dilated Cardiomyopathy in Genotype-Positive Relatives, TAVR or SAVR and Severe Aortic Stenosis

 In this week’s View, Dr. Eagle looks at a scientific statement from the American Heart Association on the diagnosis and management of cardiac sarcoidosis. He then examines the temporal trends and clinical implications of ischemic stroke in women with atrial fibrillation. Finally, Dr. Eagle shares some thoughts on transcatheter aortic valve implantation in patients with high-risk symptomatic native aortic regurgitation (ALIGN-AR).    Subscribe to Eagle’s Eye View   

Eagle’s Eye View: Cardiac Sarcoidosis, Ischemic Stroke in Women with Atrial Fibrillation, TAVR and Native Aortic Regurgitation

 In this week’s View, Dr. Eagle looks at a systematic review and meta-analysis of antibiotic prophylaxis and infective endocarditis incidence following invasive dental procedures. He then examines the issue of serious bleeding in patients with atrial fibrillation using diltiazem with apixaban or rivaroxaban. Finally, Dr. Eagle shares some thoughts on low-dose colchicine for secondary prevention in atherosclerosis.    Subscribe to Eagle’s Eye View       

Eagle’s Eye View: infective Endocarditis After Invasive Dental Procedures, Serious Bleeding in Patients with Atrial Fibrillation Using Diltiazem with Apixaban or Rivaroxaban, Low-Dose Colchicine for S

Eagle’s Eye View: Wednesday, October 25 — ACCess Points Daily Wrap Up | TCT 2023

Download our free app to listen on your phone